Novo Nordisk's new CEO, Mike Doustdar, is under significant pressure as the company contends with declining stock prices, ...
Agios maintains a robust balance sheet and is positioned for significant growth if regulatory approvals and market expansion ...
On October 29, TD Cowen analyst Brendan Smith initiated coverage of West Pharmaceutical Services, Inc. (NYSE:WST) with a Buy rating and a price target of $350, as reported by The Fly.
Pfizer (PFE), one of the world’s oldest and most respected pharmaceutical companies, is currently facing significant stock ...
2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...
Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...
Novo Nordisk asserts its acquisition of Metsera won't pose antitrust problems as it competes with Pfizer for dominance in the ...
TG Therapeutics, Inc. posted a strong Q3 with soaring Briumvi sales and increased guidance. Click for my updated look at TGTX ...
Phio Pharmaceuticals shares were higher after the company reported positive pathology results for its Phase 1b Intasyl PH-762 trial. The stock was 32% higher, at $2.72. Shares are up 55% year to date.
Terns Pharmaceuticals shares jumped after the company shared positive data for its leukemia treatment TERN-701. The stock gained 83% to $15.09 on Monday, putting it on track for its highest close ...
Key Points Israel-based Phoenix Financial acquired more than 3.5 million additional shares of Teva Pharmaceuticals for an estimated $62.1 million in the third quarter. Post-transaction, the fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback